We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

27 hedge funds and large institutions have $1.22M invested in vTv Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.07% less ownership

Funds ownership: 1.27% → 0.2% (-1.1%)

34% less funds holding

Funds holding: 41 → 27 (-14)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

56% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 25

94% less capital invested

Capital invested by funds: $20M → $1.22M (-$18.8M)

Holders
27
Holders Change
-14
Holders Change %
-34.15%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
5
Reduced
9
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$139K
2
ARTA
A.R.T. Advisors
New York
+$130K
3
Goldman Sachs
Goldman Sachs
New York
+$84.1K
4
PP
Paloma Partners
Connecticut
+$63.7K
5
Jane Street
Jane Street
New York
+$45.9K

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$3.82M
2
Franklin Resources
Franklin Resources
California
-$3.4M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$1.85M
4
RA
Royce & Associates
New York
-$1.48M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
26
Meeder Asset Management
Ohio
$944 +$1.11K +15 New
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$17 -$2.81K -38 Closed
GC
28
GMT Capital
Georgia
– -$3.82M -23,478 Closed
Franklin Resources
29
Franklin Resources
California
– -$3.4M -20,883 Closed
Massachusetts Financial Services
30
Massachusetts Financial Services
Massachusetts
– -$1.85M -11,389 Closed
RA
31
Royce & Associates
New York
– -$1.48M -9,075 Closed
JP Morgan Chase
32
JP Morgan Chase
New York
– -$1.33M -8,193 Closed
Fidelity Investments
33
Fidelity Investments
Massachusetts
– -$1.2M -7,396 Closed
SFM
34
Sphera Funds Management
Israel
– -$1.15M -7,042 Closed
State Street
35
State Street
Massachusetts
– -$424K -2,606 Closed
Alyeska Investment Group
36
Alyeska Investment Group
Illinois
– -$220K -1,349 Closed
JGC
37
J. Goldman & Co
New York
– -$106K -650 Closed
Balyasny Asset Management
38
Balyasny Asset Management
Illinois
– -$98K -605 Closed
Bank of New York Mellon
39
Bank of New York Mellon
New York
– -$90K -549 Closed
Renaissance Technologies
40
Renaissance Technologies
New York
– -$81K -495 Closed
TCIM
41
TIAA CREF Investment Management
New York
– -$61K -377 Closed
Charles Schwab
42
Charles Schwab
California
– -$50K -305 Closed
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
– -$46K -280 Closed
PAM
44
Panagora Asset Management
Massachusetts
– -$20K -122 Closed
AIG
45
American International Group
New York
– -$18K -113 Closed
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
– -$18K -108 Closed
Legal & General Group
47
Legal & General Group
United Kingdom
– -$4K -22 Closed
AIP
48
Ameritas Investment Partners
Nebraska
– -$2K -13 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– +$222 +3 New
1
2

VTVT Hedge Fund Activity: Q2 2018 in Review

27 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q2 2018, worth a combined $1.22M — down 94% from $20M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of VTVT and 11 opened new positions — a net loss of 14 holders — while 9 trimmed existing stakes and 5 added.

The largest buyer was Deutsche Bank, adding an estimated $139K. The largest seller was GMT Capital, exiting entirely with an estimated $3.82M sold.

  • 27 institutional investors held vTv Therapeutics (VTVT) as of Q2 2018, down from 41 in Q1 2018.
  • Funds reported $1.22M of vTv Therapeutics stock for Q2 2018, down 94% quarter-over-quarter.
  • 11 funds opened new vTv Therapeutics positions in Q2 2018 and 25 closed out, a net change of -14 holders.
  • The largest vTv Therapeutics buyer in Q2 2018 was Deutsche Bank, an estimated $139K added.
  • The largest vTv Therapeutics seller in Q2 2018 was GMT Capital, an estimated $3.82M sold.

Based on aggregated 13F filings for Q2 2018.